Lower incidence of chronic graft-versus-host disease after ruxolitinib plus extracorporeal photopheresis versus ruxolitinib alone in steroid-refractory acute graft-versus-host disease following allogeneic stem cell transplantation.

https://read.qxmd.com/read/40109187/lower-incidence-of-chronic-graft-versus-host-disease-after-ruxolitinib-plus-extracorporeal-photopheresis-versus-ruxolitinib-alone-in-steroid-refractory-acute-graft-versus-host-disease-following-allogeneic-stem-cell-transplantation?uac=148436CN&ecd=wnl_readmost_250404&sso=true&redirected=slug